Potential of cranberry powder for management of hyperglycemia using in vitro models

Journal of Medicinal Food

Volumn 13, Issue 5, 2010, Pages 1036-1044

  Pinto, Marcia Da Silva ^a   Ghaedian, Reza ^b   Shinde, Rahul ^b   Shetty, Kalidas ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b Decas Botanical Synergies   (United States)

Author keywords

amylase; glucosidase; angiotensin converting enzyme; antioxidant activity; cranberry powders; enzyme inhibition; phenolic phytochemicals; type 2 diabetes

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ALPHA GLUCOSIDASE; AMYLASE; CARBOXYLIC ACID; CRANBERRY EXTRACT; CRANSULIN; DIPEPTIDYL CARBOXYPEPTIDASE; PARA COUMARIC ACID; PHENOL DERIVATIVE; SUGAR; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; CRANBERRY; DRUG ACTIVITY; DRY WEIGHT; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERGLYCEMIA; HYPERTENSION; IN VITRO STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POWDER; PRIORITY JOURNAL;

ALPHA-AMYLASES; ALPHA-GLUCOSIDASES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIOXIDANTS; CARBOHYDRATES; CARBOXYLIC ACIDS; COUMARIC ACIDS; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; ENZYME INHIBITORS; FRUIT; HYPOGLYCEMIC AGENTS; PHENOLS; PHYTOTHERAPY; PLANT EXTRACTS; POWDERS; QUERCETIN; VACCINIUM MACROCARPON;

ANIMALIA; VACCINIUM MACROCARPON;

EID: 77956590152     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2009.0225     Document Type: Article

References (68)

1. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
2. Daar AS, Singer PA, Persad DL, Pramming SK, Matthews DR, Beaglehole R, Bernstein A, Borysiewicz LK, Colagiuri S, Ganguly N, Glass RI, Finegood DT, Koplan J, Nabel EG, Sarna G, Sarrafzadegan N, Smith R, Yach D, Bell J: Grand challenges in chronic non-communicable diseases. Nature 2007;450:494-496.
3. Hung HC, Joshipura KJ, Jiang R, Hu FB, Hunter D, Smith-Warner SA, Colditz GA, Rosner B, Spiegelman D, Willett WC: Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst 2004;96:1577-1584.
4. Costacou T, Mayer-Davis EJ: Nutrition and prevention of type 2 diabetes. Annu Rev Nutr 2003;23:147-170.
5. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002;106:2067-2072.
6. Joshipura KJ, Hu FB, Manson JE, Stampfer MJ, Rimm EB, Speizer FE, Colditz G, Ascherio A, Rosner B, Spiegelman D, Willett WC: The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 2001;132:1106-1114.
7. Nöthlings U, Schulze MB, Weikert C, Boeing H, Van der Schouw YT, Bamia C, Benetou V, Lagiou P, Krogh V, Beulens JWJ, Peeters PHM, Halkjær J, Tjønneland A, Tumino R, Panico S, Masala G, Clavel-Chapelon F, De Lauzon B, Boutron-Ruault MC, Vercambre MN, Kaaks R, Linseisen J, Overvad K, Arriola L, Ardanaz E, Gonzalez CA, Tormo MJ, Bingham S, Khaw KT, Key TJA, Vineis P, Riboli E, Ferrari P, Boffetta P, Bueno-de-Mesquita HB, Van der A DL, Berglund G, Wirfält E, Hallmans G, Johansson I, Lund E, Trichopoulo A: Intake of vegetables, legumes, and fruit, and risk for all-cause, cardiovascular, and cancer mortality in a European diabetic population. J Nutr 2008;138:775-781.
8. Shukitt-Hale B, Lau FC, Joseph JA: Berry fruit supplementation and the aging brain. J Agric Food Chem 2008;56:636-641.
9. Seeram NP: Berry fruits for cancer prevention: current status and future prospects. J Agric Food Chem 2008;56:630-635.
10. Juranic Z, Zizak Z: Biological activities of berries: from anti-oxidant activity to anti-cancer effects. BioFactors 2005;23:207-211.
11. Tsuda T: Regulation of adipocyte function by anthocyanins; possibility of preventing the metabolic syndrome. J Agric Food Chem 2008;56:642-646.
12. Vattem DA, Ghaedian R, Shetty K: Enhancing health benefits of berries through phenolic antioxidant enrichment: focus on cranberry. Asia Pac J Clin Nutr 2005;14:120-130.
13. Griffiths P: The role of cranberry juice in the treatment of urinary tract infections. Br J Community Nurs 2003;8:557-561.
14. Bomser J, Madhavi DL, Singletary K, Smith MAL: In vitro an-ticancer activity of fruit extracts from Vaccinium species. Planta Med 1996;62:212-216.
15. National Agricultural Statistics Service. usda.mannlib.cornell.edu=usda= nass=Cran==2000s=2001=Cran-08-21-2001.pdf (accessed May 2009).
16. Kwon YI, Vattem DV, Shetty K: Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension. Asia Pac J Clin Nutr 2006;15:107-118. (Pubitemid 43341846)
17. Matsui T, Ueda T, Oki T, Sugita K, Terahara N, Matsumoto K: a-Glucosidase inhibitory action of natural acylated anthocyanins. 1. Survey of natural pigments with potent inhibitory activity. J Agric Food Chem 2001;49:1948-1951.
18. McDougall GJ, Shpiro F, Dobson P, Smith P, Blake A, Stewart D: Different polyphenolic components of soft fruits inhibit a-amylase and a-glucosidase. J Agric Food Chem 2005;53:2760-2766.
19. Khan A, Bryden NA, Polansky MM, Anderson RA: Insulin potentiating factor and chromium content of selected foods and spices. Biol Trace Elem Res 1990;24:183-188.
20. Kotowaroo MI, Mahomoodally MF, Gurib-Fakim A, Subratty AH: Screening of traditional antidiabetic medicinal plants of Mauritius for possible a-amylase inhibitory effects in vitro. Phytother Res 2006;20:228-231.
21. Gao H, Huang YN, Xu PY, Kawabata J: Inhibitory effect on a-glucosidase by the fruits of Terminalia chebula Retz. Food Chem 2007;105:628-634.
22. Bhandari MR, Jong-Anurakkun N, Hong G, Kawabata J: a-Glucosidase and a-amylase inhibitory activities of Nepalese medicinal herb Pakhanbhed (Bergenia ciliata, Haw.). Food Chem 2008;106:247-252.
23. Ali H, Houghton PJ, Soumyanath A: a-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J Ethnopharmacol 2006;107:449-455.
24. nd ed. NIH Publication number 95-1468. U.S. Government Printing Office, Washington, DC, 1995, pp. 1-14.
25. Johnston JI, Franz V: Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. J Hypertens 1992; 10:13-26.
26. Heima KE, Tagliaferroa AR, Bobilya DJ: Flavonoid antioxi-dants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem 2002;13:572-584.
27. Apostolidis E, Kwon YI, Shetty K: Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymes linked to type 2 diabetes and hypertension. Innov Food Sci Emerg Technol 2007;8:46-54.
28. Chambers BK, Camire ME: Can cranberry supplementation benefit adults with type 2 diabetes? Diabetes Care 2003;26: 2695-2696.
29. Shetty K, Curtis OF, Levin RE, Wikowsky R, Ang W: Prevention of vitrification associated with in vitro shoot culture of oregano (Origanum vulgare) by Pseudomonas spp. J Plant Physiol 1995; 147:447-451.
30. Worthington V, ed.: Alpha amylase. In: Worthington Enzyme Manual. Worthington Biochemical Corp., Freehold, NJ, 1993, pp. 36-41.
31. Worthington V, ed.: Maltase-a-glucosidase. In: Worthington Enzyme Manual. Worthington Biochemical Corp., Freehold, NJ, 1993, p. 261.
32. McCue P, Kwon YI, Shetty K: Anti-amylase, anti-glucosidase and anti-angiotensin I-converting enzyme potential of selected foods. J Food Biotechnol 2005;29:278-294.
33. th ed. AOAC, Washington, DC, 1995.
34. Shaw DV: Genotypic variation and genotypic correlation for sugars and organic acids for strawberries. J Am Soc Hort Sci 1988;113:770-774.
35. Scalzo RL: Organic acids influence on DPPH scavenging by ascorbic acid. Food Chem 2008;107:40-43.
36. Ryan JJ, Dupont JA: Identification and analysis of the major acids from fruit juices and wines. J Agric Food Chem 1973; 21:45-49.
37. Kafkas E, Kosar M, Turemis N, Baser KHC: Analysis of sugars, organic acids and vitamin C contents of blackberry genotypes from Turkey. Food Chem 2006;97:732-736.
38. Gökmen V, Acar J: An investigation on the relationship between patulin and fumaric acid in apple juice concentrates. LWT Food Sci Technol 1998;31:480-483.
39. Prior RL, Gu L, Wu X, Jacob RA, Sotoudeh G, Kader AA, Cook RA: Plasma antioxidant capacity changes following a meal as a measure of the ability of a food to alter in vivo antioxidant status. J Am Coll Nutr 2007;26:170-181.
40. Eastwood MA: Interaction of dietary antioxidants in vivo: how fruit and vegetables prevent disease? Q J Med 1999;92:527-530.
41. Middleton E, Kandaswami C: The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In: The Flavonoids. Advances in Research Since 1986 (Harborne JB, ed.). Chapman & Hall, London, 1994, pp. 619-652.
42. Vinson JA, Zubik L, Bose P, Samman N, Proch J: Dried fruits: excellent in vitro and in vivo antioxidants. J Am Coll Nutr 2005;24:44-50.
43. Sun J, Chu Y, Wu X, Liu RH: Antioxidant and antiproliferative activities of common fruits. J Agric Food Chem 2002;50:7449-7454. (Pubitemid 35424917)
44. Pedersen CB, Kyle J, McE Jenkinson A, Gardner PT, McPhail DB, Duthie GG: Effects of blueberry and cranberry juice consumption on the plasma antioxidant capacity of healthy female volunteers. Eur J Clin Nutr 2002;54:405-408.
45. Ruel G, Pomerleau S, Couture P, Lamarche B, Couillard C: Changes in plasma capacity and oxidized low-density lipoprotein levels in men after short-term cranberry juice consumption. Metabolism 2005;54:856-861.
46. Duthie SJ, Jenkinson AM, Crozier A, Mullen W, Pirie L, Kyle J, Yap LS, Christen P, Duthie GG: The effects of cranberry juice consumption on antioxidant status and biomarkers relating to heart disease and cancer in healthy human volunteers. Eur J Nutr 2006;45:113-122.
47. Bilyk A, Cooper P, Sapers GM: Varietal differences in distribution of quercetin and kaempferol in onion (Allium sepa L.) tissue. J Agric Food Chem 1984;32:274-276
48. Koo HM, Suhaila M: Flavonoid (myricetin, quercetin, kaemp-ferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem 2001;49:3106-3112.
49. Justesen U, Khuthsen P, Leth T: Quantitative analysis of flavo-nols, flavones, and flavanones in fruits, vegetables and beverages by high-performance liquid chromatography with photodiode array and mass spectrometric detection. J Chromatogr A 1998; 799:101-110.
50. Häkkinen S, Heinonen M, Kärenlampi S, Mykkänen H, Ruus-kanen J, Törrönen R: Screening of selected flavonoids and phenolic acids in 19 berries. Food Res Int 1999;32:345-353.
51. Zheng W, Wang SY: Oxygen radical absorbing capacity of phenolics in blueberries, cranberries, chokeberries, and lingon-berries. J Agric Food Chem 2003;51:502-509.
52. Wilson T, Meyers SL, Singh AP, Limburg PJ, Vorsa N: Favorable glycemic response of type 2 diabetics to low calorie cranberry juice. J Food Sci 2008;73:241-245.
53. Chen H, Zuo Y, Deng Y: Separation and determination of fla-vonoids and other phenolic compounds in cranberry juice by high-performance liquid chromatography. J Chromatogr A 2001; 913:387-395.
54. Clifford MN: Chlorogenic acids and other cinnamates\nature, occurrence, dietary burden, absorption and metabolism. J Sci Food Agric 2000;80:1033-1042.
55. World Health Organization: Diabetes. Fact Sheet 2006; 312. www.who.int=mediacentre=factsheets=fs312=en=print.html (accessed April 21, 2008).
56. rd ed. (Pickup JC, William G, eds.). Blackwell Science Ltd., Oxford, 2003, pp. 73.1-73.21.
57. Broadhurst CL: Nutrition and non-insulin dependent diabetes from an anthropological perspective. Altern Med Rev 1997;2: 378-399.
58. Pinto MS, Kwon Y-I, Apostolidis E, Lajolo FM, Genovese MI, Shetty K: Functionality of bioactive compounds of Brazilian strawberry (Fragaria x ananassa Duch.) cultivars: evaluation of hyperglycemia and hypertension potential. J Agric Food Chem 2008;56:4386-4392.
59. Apostolidis E, Kwon YI, Shetty K: Potential of cranberry-based herbal synergies for diabetes and hypertension management. Asia Pac J Clin Nutr 2006;15:433-441. (Pubitemid 44423426)
60. Puls W, Keup U, Krause H, Thomas PG, Hoffmeister F: Glu-cosidase inhibition: a new approach to the treatment of diabetes, obesity, and hyperlipoproteinemia. Naturwissenschaften 1977;64: 536-537. (Pubitemid 8197894)
61. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-223.
62. Taubert D, Berkels R, Roesen R, Klaus W: Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA 2003;290:1029-1030.
63. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N: A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997;336:1117-1124.
64. Chen ZY, Peng C, Jiao R, Wong YM, Yang N, Huang Y: Anti-hypertensive nutraceuticals and functional foods. J Agric Food Chem 2009;57:4485-4499.
65. Machha A, Achike FI, Mustafa AM, Mustafa MR: Quercetin, a flavonoid antioxidant, modulates endothelium-derived nitric oxide bioavailability in diabetic rat aortas. Nitric Oxide 2007; 16:442-447.
66. Shaw A, Bott R, Day AG: Protein engineering of a-amylase for low pH performance. Curr Opin Biotechnol 1999;10:349-352.
67. Chen YT, Kao WT, Lin KW: Effects of pH on the total phenolic compounds, antioxidative ability and the stability of dioscorin of various yam cultivars. Food Chem 2008;107:250-257.
68. Friedman M, Jurgens HS: Effect of pH on the stability of plant phenolic compounds. J Agric Food Chem 2000;48:2101-2110.